Express News | Neurocrine Biosciences Inc : BMO Raises Target Price to $121 From $114

ReutersOct 31 10:44 ET

Morgan Stanley Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $170

Moomoo NewsOct 31 09:40 ET · Ratings

Evercore Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $175

Moomoo NewsOct 31 09:40 ET · Ratings

A Quick Look at Today's Ratings for Neurocrine Biosciences(NBIX.US), With a Forecast Between $136 to $192

Moomoo NewsOct 31 09:00 ET · Ratings

Neurocrine Biosciences Analyst Ratings

BenzingaOct 31 06:40 ET · Ratings

Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight

Yahoo FinanceOct 31 01:09 ET